title: Neuroleptic rechallenge after neuroleptic malignant syndrome.
authors.forename: M
authors.initials: M
authors.lastname: Giacardi-Paty
authors.forename: T
authors.initials: T
authors.lastname: Bottai
authors.forename: D
authors.initials: D
authors.lastname: Pujalte
authors.forename: E
authors.initials: E
authors.lastname: Lainey
authors.forename: P
authors.initials: P
authors.lastname: Petit
mesh_terms: D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003024:Clozapine / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D009460:Neurologic Examination / Q000187:drug effects; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D012008:Recurrence; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents; D003024:Clozapine